Halozyme Therapeutics, Inc.
HALO · NASDAQ · USD
$110.42
+0.58 0.53%todayNot financial advice.
- Open
- 109.70
- Day range
- 109.70 - 112.65
- 52-week range
- 61.23 - 116.85
- Volume
- 1.85M
- Market cap
- 12.53B
- P/E ratio
- 32.99
- EPS
- 3.52
- Dividend yield
- 0.00%
- Beta
- 0.67
Performance
W
+3.23%
1M
+2.55%
3M
+40.09%
6M
+63.97%
YTD
+63.08%
Y
+69.36%
5Y
+186.14%
All
+2,844.53%
In the news
Oct 8
Halozyme Wins European Court Order Blocking Merck's Keytruda SC
A Dutch court blocked Merck from selling its subcutaneous Keytruda in eight European nations, giving Halozyme a key patent victory.
Company news
Oct 7
Halozyme Secures European Injunction Blocking Merck's Keytruda SC
Halozyme Therapeutics secured a European court injunction blocking Merck's Keytruda SC, strengthening its IP position and disrupting a rival product.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-HALO" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Halozyme Therapeutics, Inc. (HALO) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-HALO">HALO stock price</a> by FreeTheAI Stocks</p>